Investigating the Impact of Circulating MicroRNAs on Knee and Hip Osteoarthritis: Causal Links, Biological Mechanisms, and Drug Interactions
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms26010283 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Shanni Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100010, China. Hauptthemen laut MEDLINE: Osteoarthritis, Hip, Osteoarthritis, Knee, Circulating MicroRNA, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Osteoarthritis (OA), particularly in the knee and hip, poses a significant global health challenge due to limited therapeutic options. To elucidate the molecular mechanisms of OA and identify potential biomarkers and therapeutic targets, we utilized genome-wide association studies (GWAS) and cis-miRNA expression quantitative trait loci (cis-miR-eQTL) datasets to identify miRNAs associated with OA, revealing 16 that were linked to knee OA and 21 to hip OA. Among these, hsa-miR-1303 was significantly upregulated in both knee and hip OA (IVW: p = 6.8164×10−36 and 4.7919×10−2 respectively, OR > 1) and identified as a key factor in disease progression. Hsa-miR-1303 potentially regulates 30 genes involved in critical signaling pathways, such as the neurotrophin signaling pathway, and interacts with competing endogenous RNAs (ceRNAs) like circ_0041843 and LINC01338, thereby influencing key regulatory proteins such as SUMO2 and PARP1. Pharmacologically, hsa-miR-1303 targets nine druggable genes, including NRAS, H2AZ1, and RPS3, which have implications for drugs like cantharidin and diindolylmethane, potentially critical for developing novel OA treatments. Conversely, hsa-miR-125a-5p and hsa-miR-125b-5p, which are downregulated in both knee and hip OA, are associated with pathways such as HIF-1 and JAK-STAT, which modulate apoptotic signaling and transcriptional regulation. These miRNAs also interact with ceRNAs such as circ_0000254 and SPACA6P-AS, impacting proteins like STAT3, MCL1, and TRAF6. A drug interaction analysis identified 47 potential treatments, including Resveratrol and Acetaminophen, suggesting new therapeutic possibilities for OA management. This study not only highlights the role of miRNAs like hsa-miR-1303 and hsa-miR-125 in OA but also opens avenues for miRNA-based therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100010, China.
- College of Computer Science and Software Engineering, Shenzhen University, Shenzhen 518060, China.
- School of Medicine, Tsinghua University, Beijing 100084, China.
Förderung
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Li, S., Peng, Y., Yu, Y., Xu, H., Yin, Z., Du, Y., Ma, M., Ji, Z., & Qian, W. (2024). Investigating the Impact of Circulating MicroRNAs on Knee and Hip Osteoarthritis: Causal Links, Biological Mechanisms, and Drug Interactions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010283
Vancouver
Li S, Peng Y, Yu Y, Xu H, Yin Z, Du Y, et al. Investigating the Impact of Circulating MicroRNAs on Knee and Hip Osteoarthritis: Causal Links, Biological Mechanisms, and Drug Interactions. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010283
BibTeX
@article{Li2024,
author = {Li, Shanni and Peng, Yihui and Yu, Yang and Xu, Hongjun and Yin, Zhaojing and Du, Yiyang and Ma, Mingyang and Ji, Zhongyin and Qian, Wenwei},
title = {Investigating the Impact of Circulating MicroRNAs on Knee and Hip Osteoarthritis: Causal Links, Biological Mechanisms, and Drug Interactions},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms26010283}
}
EUVIMED